Peter Rusert
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1.
Journal: PLoS pathogens
Published: February 12, 2025
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.
Journal: Cell host & microbe
Published: September 10, 2024
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.
Journal: PLoS pathogens
Published: June 23, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.
Journal: Cell reports. Medicine
Published: February 26, 2024
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection.
Journal: mBio
Published: January 25, 2024
Assessing immunogenicity barriers of the HIV-1 envelope trimer.
Journal: NPJ vaccines
Published: April 12, 2023
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralization.
Journal: Nature structural & molecular biology
Published: September 23, 2022
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus.
Journal: The Journal of general virology
Published: June 07, 2022
Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4+ T cells: A pooled data-analysis.
Journal: Frontiers in immunology
Published: April 08, 2022
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Journal: The Journal of clinical investigation
Published: January 06, 2022
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity.
Journal: Nature communications
Published: April 14, 2021
Last Updated: 09/26/2026